These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21970497)

  • 1. Interaction between resveratrol and thrombin and its biological implication.
    Zhang J; Yu WJ; Yang N; Sun L
    Int J Food Sci Nutr; 2011 Dec; 62(8):814-20. PubMed ID: 21970497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resveratrol-induced platelet apoptosis.
    Lin KH; Hsiao G; Shih CM; Chou DS; Sheu JR
    Cardiovasc Res; 2009 Aug; 83(3):575-85. PubMed ID: 19423619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet-neutrophil interactions.
    Kaneider NC; Mosheimer B; Reinisch N; Patsch JR; Wiedermann CJ
    Thromb Res; 2004; 114(3):185-94. PubMed ID: 15342215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin.
    Olas B; Wachowicz B; Szewczuk J; Saluk-Juszczak J; Kaca W
    Microbios; 2001; 105(410):7-13. PubMed ID: 11368092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of resveratrol on platelet aggregation in vivo and in vitro.
    Wang Z; Zou J; Huang Y; Cao K; Xu Y; Wu JM
    Chin Med J (Engl); 2002 Mar; 115(3):378-80. PubMed ID: 11940369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies.
    Crescente M; Jessen G; Momi S; Höltje HD; Gresele P; Cerletti C; de Gaetano G
    Thromb Haemost; 2009 Aug; 102(2):336-46. PubMed ID: 19652885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol preserves the function of human platelets stored for transfusion.
    Lannan KL; Refaai MA; Ture SK; Morrell CN; Blumberg N; Phipps RP; Spinelli SL
    Br J Haematol; 2016 Mar; 172(5):794-806. PubMed ID: 26683619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol, a phenolic antioxidant with effects on blood platelet functions.
    Olas B; Wachowicz B
    Platelets; 2005 Aug; 16(5):251-60. PubMed ID: 16011975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets.
    Olas B; Saluk-Juszczak J; Wachowicz B
    Cell Biol Toxicol; 2008 Apr; 24(2):189-99. PubMed ID: 17846905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiaggregant effects of Arbutus unedo extracts in human platelets.
    El Haouari M; López JJ; Mekhfi H; Rosado JA; Salido GM
    J Ethnopharmacol; 2007 Sep; 113(2):325-31. PubMed ID: 17681442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stilbenoids from Gnetum macrostachyum attenuate human platelet aggregation and adhesion.
    Kloypan C; Jeenapongsa R; Sri-in P; Chanta S; Dokpuang D; Tip-pyang S; Surapinit N
    Phytother Res; 2012 Oct; 26(10):1564-8. PubMed ID: 22511550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecotin modulates thrombin activity through exosite-2 interactions.
    Castro HC; Monteiro RQ; Assafim M; Loureiro NI; Craik C; Zingali RB
    Int J Biochem Cell Biol; 2006; 38(11):1893-900. PubMed ID: 16843700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-platelet effects of different phenolic compounds from Yucca schidigera Roezl. bark.
    Olas B; Wachowicz B; Stochmal A; Oleszek W
    Platelets; 2002 May; 13(3):167-73. PubMed ID: 12180499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids.
    Vilar S; Quezada E; Santana L; Uriarte E; Yánez M; Fraiz N; Alcaide C; Cano E; Orallo F
    Bioorg Med Chem Lett; 2006 Jan; 16(2):257-61. PubMed ID: 16275073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol, a natural phenolic compound may reduce carbonylation proteins induced by peroxynitrite in blood platelets.
    Olas B; Nowak P; Ponczek M; Wachowicz B
    Gen Physiol Biophys; 2006 Jun; 25(2):215-22. PubMed ID: 16917134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of blood platelets to resveratrol during a model of hyperhomocysteinemia.
    Malinowska J; Olas B
    Platelets; 2011; 22(4):277-83. PubMed ID: 21557714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
    Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
    Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-platelet effects of yuzu extract and its component.
    Yu HY; Park SW; Chung IM; Jung YS
    Food Chem Toxicol; 2011 Dec; 49(12):3018-24. PubMed ID: 22005257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
    Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ
    Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.